Movement Alert｜10x Genomics, Inc. Intraday Rise 5.06%, Atera Commercial Shipments Launched Amid Positive Analyst Rating

Market Focus10-06 03:47

On October 6, 10x Genomics, Inc. rose 5.06% in regular trading, trading at $98.25 per share, with turnover of $187 million.

The movement aligns with the company's announcement of first commercial shipments for the Atera spatial biology platform, which combines whole-transcriptome analysis and single-cell resolution functionality for AI biology models, alongside Argus Research's buy rating and $110 target price issued last week.

Argus's target exceeds FactSet's average analyst consensus by 87%, while sector peers Illumina and Tempus AI gained 8.21% and 8.86% respectively, highlighting capital flows into technology platform-driven stocks in life sciences tools.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment